NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.44
-1.81 (-4.99%)
At close: Apr 14, 2026, 4:00 PM EDT
34.50
+0.06 (0.17%)
After-hours: Apr 14, 2026, 5:06 PM EDT

NAMS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22.545.5614.09102.69-
Revenue Growth (YoY)
-50.61%223.37%-86.28%--
Gross Profit
22.545.5614.09102.69-
Selling, General & Admin
106.3570.4537.63-22.91-5.46
Research & Development
141.83151.41159.42-88.46-28.47
Other Operating Expenses
---62.26-
Total Operating Expenses
248.19221.85197.06-49.11-33.93
Operating Income
-225.68-176.29-182.97-70.94-33.93
Interest Income
27.5916.8811.280.010.01
Interest Expense
----0.29-0.25
Other Non-Operating Income (Expense)
-5.73-82.19-5.23-10.791.64
Total Non-Operating Income (Expense)
21.86-65.316.06-11.061.41
Pretax Income
-203.82-241.6-176.91-82-32.52
Provision for Income Taxes
--00.03--
Net Income
-203.82-241.6-176.94-82-32.52
Net Income to Common
-203.82-241.6-176.94-82-32.52
Shares Outstanding (Basic)
11894824024
Shares Outstanding (Diluted)
11894824024
Shares Change (YoY)
25.50%14.84%107.33%67.66%156.56%
EPS (Basic)
-1.72-2.56-2.15-2.11-1.38
EPS (Diluted)
-1.72-2.56-2.15-2.11-1.38
Shares Outstanding
114.4108.0682.4781.56-
Free Cash Flow
-148.03-159.24-141.247.02-28.64
Free Cash Flow Per Share
-1.25-1.69-1.720.18-1.21
Gross Margin
100.00%100.00%100.00%100.00%-
Operating Margin
-1002.90%-386.91%-1298.56%-69.08%-
Profit Margin
-905.74%-530.25%-1255.76%-79.85%-
FCF Margin
-657.82%-349.49%-1002.43%6.83%-
EBITDA
-225.46-176.18-182.92-70.86-33.91
EBITDA Margin
-1001.92%-386.66%-1298.21%-69.00%-
EBIT
-225.68-176.29-182.97-70.94-33.93
EBIT Margin
-1002.90%-386.91%-1298.56%-69.08%-
Effective Tax Rate
0.00%0.00%-0.02%0.00%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q